Fresenius Medical Care AG
FMS24.985USD
-0.085-0.34%
Fechamento 04/29, 16:00（ET）Cotações atrasadas em 15 min
7.33BValor de mercado
10.26P/L TTM
Mais detalhes de Fresenius Medical Care AG Empresa
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Informações da empresa
Código da empresaFMS
Nome da EmpresaFresenius Medical Care AG
Data de listagemOct 02, 1996
Fundado em2006
CEODr. Katarzyna Mazur-Hofsaess
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 02
EndereçoElse-Kroener-Strasse 1
CidadeBAD HOMBURG VOR DER HOHE
Bolsa de valoresTSX Venture Exchange (former Canadian Ventures Exchange)
PaísGermany
Código postal61352
Telefone4961726090
Sitehttps://www.freseniusmedicalcare.com/
Código da empresaFMS
Data de listagemOct 02, 1996
Fundado em2006
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Stefanie Balling
Ms. Stefanie Balling
Vice Chairman of the Supervisory Board
Vice Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Ralf Erkens
Mr. Ralf Erkens
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Detalhamento da receita
Moeda: USDTempo de atualização: qui, 20 de fev
Moeda: USDTempo de atualização: qui, 20 de fev
FY2022
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
North America
14.27B
69.95%
Rest of the world
5.62B
27.54%
Germany
512.41M
2.51%
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Estatísticas dos acionistas
Acionista
Proporção
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
5.01%
Investment Advisor
2.07%
Hedge Fund
0.32%
Research Firm
0.07%
Family Office
0.01%
Other
92.52%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
321
44.02M
7.50%
-2.98M
2024Q4
337
43.96M
7.49%
-3.12M
2024Q3
324
43.49M
7.41%
-1.75M
2024Q2
342
41.23M
7.03%
-8.59M
2024Q1
361
42.90M
7.31%
-5.86M
2023Q4
361
42.80M
7.29%
-6.45M
2023Q3
365
42.72M
7.28%
-7.66M
2023Q2
367
43.73M
7.45%
-13.55M
2023Q1
371
50.41M
8.59%
-15.36M
2022Q4
381
58.35M
9.94%
+10.96M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Pzena Investment Management, LLC
15.28M
2.6%
-932.64K
-5.75%
Dec 31, 2024
Wellington Management Company, LLP
8.20M
1.4%
--
--
Dec 31, 2024
Fiduciary Management, Inc.
6.31M
1.07%
-252.52K
-3.85%
Dec 31, 2024
Dodge & Cox
4.17M
0.71%
--
--
Dec 31, 2024
Aristotle Capital Management, LLC
1.16M
0.2%
--
--
Dec 31, 2024
Parametric Portfolio Associates LLC
973.20K
0.17%
+51.68K
+5.61%
Dec 31, 2024
Millennium Management LLC
722.24K
0.12%
+708.86K
+5.30K%
Dec 31, 2024
Integral Health Asset Management, LLC
600.00K
0.1%
+150.00K
+33.33%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
530.60K
0.09%
+76.80K
+16.92%
Dec 31, 2024
Janus Henderson Investors
528.22K
0.09%
+114.50K
+27.67%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
The Opal International Dividend Income ETF
1.67%
Cultivar ETF
1.49%
ActivePassive International Equity ETF
0.16%
Avantis Responsible International Equity ETF
0.04%
Avantis International Equity ETF
0.01%
Unusual Whales Subversive Republican Trading ETF
0%
Pacer Developed Markets International Cash Cws 100
0%
Inspire Fidelis Multi Factor ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Ver Mais
The Opal International Dividend Income ETF
Proporção1.67%
Cultivar ETF
Proporção1.49%
ActivePassive International Equity ETF
Proporção0.16%
Avantis Responsible International Equity ETF
Proporção0.04%
Avantis International Equity ETF
Proporção0.01%
Unusual Whales Subversive Republican Trading ETF
Proporção0%
Pacer Developed Markets International Cash Cws 100
Proporção0%
Inspire Fidelis Multi Factor ETF
Proporção0%
Unusual Whales Subversive Democratic Trading ETF
Proporção0%
DFA Dimensional International Core Equity 2 ETF
Proporção0%
Dividendo
Um total de
1.94B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados